An international conference on “All you should know about thrombosis” was held at the Yerevan State Medical University (YSMU) on January 19-20, 2018. The conference brought together many local and international experts to exchange knowledge and experience.
The International Society on Thrombosis and Haemostasis (ISTH) organized the conference in collaboration with the YSMU, Armenian Association of Cardiologists, Armenian Association of Hematology and Oncology, and Heratsi iLAB.
Thrombosis is a huge public health concern all around the globe.1 The conference aimed to promote more competent approaches to diagnosing, treating, and preventing thrombosis among Armenian physicians. The best experts from Armenia and abroad made presentations on various topics during the two-day conference. Frits Rosendaal, Professor at the Leiden University, former President of the International Union of Thrombosis and Hemostasis, President of the Netherlands Thrombosis and Hemostasis Union, spoke about vein thrombosis, epidemiological and risk factors, as well as the association between hormones and thrombosis. This doctor-scientist had a long career in thrombosis and hemostasis and, in 2003, was awarded the highest scientific award in the Netherlands, “The Spinoza Prize.”
Many other renowned specialists presented during the conference, such as:
- Michael Graves, the vice-rector of the University of Aberdeen and former head of the School of Medicine
- Dr. Flora Peyvandi, Professor at the University of Milan
- Marco Moya, the head of the Italian Federation of Anticoagulation Clinics
- Hunan Julhakyan, Scientific Secretary of the Russian National Research Center for Hematology
One out of every four people dies because of thrombosis.1 Even though thrombosis can be prevented, many people are not timely diagnosed and face serious issues, such as disability or death.2
In his lecture, Dr. Graves stated that multiple prognostic factors predict thrombosis, and genetics does not play a key role in it. Referring to pregnancy, which is a risk factor for thrombosis, Dr. Graves noted that pregnant women have 8 to 10 times higher risk of developing thrombosis.3
Dr. Gevorg Tamamyan, a pediatric oncologist-hematologist in the Muratsan Chemotherapy Clinic and a lecturer at the Oncology Department in the Yerevan State Medical University, stated that this is a great opportunity for the doctors to get aware of the experience of renowned scientists and about the international treatment practices of thrombosis and to discuss their personal experience with them. Dr. Tamamyan also mentioned this is the first event gathering professionals around this topic in Armenia.
Article from aravot.am
- Wendelboe AM, Raskob GE. Global Burden of Thrombosis: Epidemiologic Aspects. Circ Res. 2016;118(9):1340-1347. doi:10.1161/CIRCRESAHA.115.306841
- Wang K-L, Chu P-H, Lee C-H, et al. Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis. Acta Cardiol Sin. 2016;32(1):1-22. doi:10.6515/ACS20151228A
- Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus. 2011;9(2):120-138. doi:10.2450/2010.0066-10